MedTrace Logo

Performance Evaluation of Tattoo Removal

NCT03866304 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-03-07

No results posted yet for this study

Summary

Evaluate safety and efficacy of S2 multi-wavelength laser for tattoo removal

Conditions

  • Tattoo Removal

Interventions

DEVICE

Device: S2 Picosecond laser

Each subject will receive up to 16 laser treatments.

Sponsors & Collaborators

  • LigthSense Israel Ltd

    lead INDUSTRY

Principal Investigators

  • Ruta Ganceviciene,, Dr · Santara KTC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-21
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Lithuania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03866304 on ClinicalTrials.gov